In another solid tumor commonly reporting IDH1 mutations, flow cytometric, immunohistochemical, and single-cell RNA sequencing analyses have observed that tumors harboring IDH1 mutations may be considered immunologically “cold” compared to wild-type gliomas, given the lower presence of CD8+ T cells and Treg cells [21,22]. This evidence concerns the gene IDH1 and glioma.